Palasis Maria insider trades
Palasis Maria has filed 18 Form 4s with the SEC that we hold, for Lyra Therapeutics, Inc. (LYRA) (Principal Executive Officer, Director) and Beta Bionics, Inc. (BBNX) (Director). Across all of them we count 0 purchases worth $0 and 6 sales worth $99.1K reported on Form 4. In the last 12 months: 0 purchases ($0) and 5 sales ($85.1K). The largest single trade was a sale of 1,287 shares of Beta Bionics, Inc. worth $34.6K, dated 2025-10-31. The first filing on our record is dated 2022-02-15 and the latest 2026-05-26.
Lyra Therapeutics, Inc. (LYRA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-07-10 | S, sale reported on Form 4 | 1,565 | $13.9K | 2025-07-14 |
| 2026-01-06 | S, sale reported on Form 4 | 1,702 | $5.7K | 2026-01-08 |
Beta Bionics, Inc. (BBNX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-10-31 | S, sale reported on Form 4 | 1,287 | $34.6K | 2025-11-05 |
| 2025-10-31 | S, sale reported on Form 4 | 119 | $3.3K | 2025-11-05 |
| 2025-12-01 | S, sale reported on Form 4 | 906 | $26.6K | 2025-12-02 |
| 2025-12-01 | S, sale reported on Form 4 | 500 | $15.0K | 2025-12-02 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1810701) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms